AN EXPERTS FORUM IN TOKYO AND SINGAPORE ON DDR AND PARP INHIBITION

DDR and PARPi Experts forums were held with an expert faculty in Tokyo and Singapore in January 2020, with the following educational objectives:
To learn about the role of PARP inhibitors in clinical practice and targeting DDR, including:

  • Mechanism of Action of PARP inhibition and targeting DDR
  • Clinical profile of PARP inhibitors and their benefit in ovarian and breast cancer
  • Appropriate patient selection for PARP inhibition
  • Future DDR and PARP inhibition

Slides available for download:

DOWNLOAD THE SLIDES – TOKYO
DOWNLOAD THE SLIDES – SINGAPORE

AstraZeneca has provided a sponsorship grant towards this independent programme.